non-PEGylated butyrylcholinesterase (Altimmune)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namenon-PEGylated butyrylcholinesterase (Altimmune)
Drug Alias Namenon-PEG-rBChE (PharmAthene)non-PEGylated butyrylcholinesterase (PharmAthene)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionCholinesterase activators
TargetsCholinesterase
Therapy Area/IndicationsAlzheimer Disease +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNexia Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmathene IncNexia Biotechnologies IncAltimmune Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease +[2] 

Other Information

ATC CodeN/A
Related LinksN/A